Web Analytics
Cổ phiếu NGEN (NASDAQ) | NERVGEN PHARMA CORP. – Phân tích Deepscope
MARKET

Select Market Data Region

NGEN — NERVGEN PHARMA CORP. (Healthcare >> Biotechnology)

NGEN FAQ

What is NGEN's ROE?

NERVGEN PHARMA CORP. reports a Return on Equity (ROE) of -843.62%.

What is NGEN's dividend yield?

NERVGEN PHARMA CORP. offers a dividend yield of 0.00%.

What is NGEN's Deepscope Quality Score?

Deepscope rates NGEN's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NGEN?

Deepscope's AI Timing Score for NGEN is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NGEN belong to?

NERVGEN PHARMA CORP. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-05 | FS: 2026-03-31)

NGEN

NERVGEN PHARMA CORP.
USD 1.86
-0.15 (-7.46%) Day Change
2.75
D/E
-843.6%
ROE
-225.1%
ROA
0.00%
Div Yield
USD 1.86
Price
-0.15 (-7.46%)
Day Change
NEWS SCORE: 97

NGEN Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) và Thời điểm mua ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng 42%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 97
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 1.86
  PBV / Sector
36.63 / 4.63
  Earning Per Share -0.43
  PE / Sector
N/A / 17.43
  PEG or PE/Growth / Sector
N/A / 0.53
  Average 1M Daily Value
3.06 M
GREAT
  Average 1W Daily Value
2.01 M
GREAT
Yếu tố Kỹ thuật 28%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 41%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 37%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
N/A / 449.48
  NPM Average (%) / Sector
N/A / -1,506.49
  NPM Change Average (%) / Sector
N/A / 4,940.99
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-225.13 / 30.58
  ROA Average (%) / Sector
-158.86 / -347.17
  ROA Change Average (%) / Sector
35.10 / 5,125.52
GREAT
  ROE (%) / Sector
-843.62 / -3.58
  ROE Average (%) / Sector
-416.82 / 40.65
  ROE Change Average (%) / Sector
-251.16 / 2,109.80
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 8%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 4.17
Chi tiết đăng ký
X
  Analyze Date 2026-06-06 09:09:04
  Symbol NGEN
  Name NERVGEN PHARMA CORP.
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 106.20 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 202.85 / 8,857.28
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 112-970 Burrard Street, Vancouver, BC, Canada, V6Z 2R4

Phone: 778-731-1711

Website: https://nervgen.com

Sector: Healthcare >> Biotechnology

Description: NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.

ME vs SECTOR Healthcare >> Biotechnology

NGEN (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
NGEN
NGEN
USD 1.86 (-7.46%)
+ Watch + Port Chart